7Baggers
 Aptevo Participating in the BIO International Convention  ACCESS Newswire Fri, 26 Sep 2025 09:24:46 GMT
 | marketbeat  MarketBeat Sun, 21 Sep 2025 07:00:00 GMT
 aptevo therapeutics stock plummets to new 52-week low of $1.32  Markets Mojo Fri, 19 Sep 2025 09:18:22 GMT
 morning market movers: etnb, apvo, pbm, beem see big swings  RTTNews Thu, 18 Sep 2025 11:43:00 GMT
 Why Is Aptevo Therapeutics Stock (APVO) Up 85% Today?  TipRanks Thu, 18 Sep 2025 07:00:00 GMT
 Aptevo Therapeutics: Surprising Results in AML Trial!  StocksToTrade Thu, 18 Sep 2025 07:00:00 GMT
 Nasdaq Surges 100 Points; US Initial Jobless Claims Fall  Benzinga Thu, 18 Sep 2025 07:00:00 GMT
 intel, nike, aptevo  TradingView Thu, 18 Sep 2025 07:00:00 GMT
 aptevo soars after billionaire investor discloses stake  TradingView Thu, 18 Sep 2025 07:00:00 GMT
 biotech stocks to add to your watchlist - september 16th  MarketBeat Wed, 17 Sep 2025 17:28:31 GMT
 aptevo announces 100% remission in aml trial  TipRanks Wed, 17 Sep 2025 01:51:41 GMT
 apvo stock surge: a time to consider?  timothysykes.com Tue, 16 Sep 2025 21:03:00 GMT
 aptevo therapeutics hits new 52-week low at $1.41  Markets Mojo Tue, 16 Sep 2025 14:34:23 GMT
 Aptevo Therapeutics Surge: New Molecules Boost Stock  StocksToTrade Tue, 16 Sep 2025 07:00:00 GMT
 Aptevo Therapeutics stock soars after 100% remission rate in AML trial  Investing.com Tue, 16 Sep 2025 07:00:00 GMT
 Why Is Aptevo Therapeutics Stock (APVO) Up 50% Today?  TipRanks Tue, 16 Sep 2025 07:00:00 GMT
 Aptevo Therapeutics shares spike on promising trial results for leukemia therapy  Proactive financial news Tue, 16 Sep 2025 07:00:00 GMT
 Market movers: Webtoon Entertainment, Hershey, Rocket Lab, Aptevo Therapeutics…  Proactive financial news Tue, 16 Sep 2025 07:00:00 GMT
 Aptevo Therapeutics (APVO) Shows Promising Results in AML Treatm  GuruFocus Tue, 16 Sep 2025 07:00:00 GMT
 Aptevo Announces 100% Remission in AML Trial  TipRanks Tue, 16 Sep 2025 07:00:00 GMT
 aptevo expands cancer pipeline with two new trispecific therapies by investing.com  Investing.com Nigeria Fri, 05 Sep 2025 10:13:01 GMT
 Aptevo Therapeutics unveils new trispecific immune cell engagers  BioWorld MedTech Fri, 05 Sep 2025 07:00:00 GMT
 Aptevo Therapeutics Expands Anti-Cancer Pipeline with Patents  TipRanks Thu, 04 Sep 2025 07:00:00 GMT
 Aptevo expands cancer pipeline with two new trispecific therapies  Investing.com Thu, 04 Sep 2025 07:00:00 GMT
 published on: 2025-09-03 23:46:32  Newser Thu, 04 Sep 2025 04:46:32 GMT
 published on: 2025-09-02 03:29:00  Newser Tue, 02 Sep 2025 08:29:00 GMT
 published on: 2025-09-01 20:43:15  Newser Tue, 02 Sep 2025 01:43:15 GMT
 published on: 2025-08-31 00:36:04  Newser Sun, 31 Aug 2025 05:36:04 GMT
 published on: 2025-08-28 16:04:13  Newser Thu, 28 Aug 2025 21:04:13 GMT

Aptevo Therapeutics Inc
(NASDAQ:APVO) 

APVO stock logo

Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. Its lead clinical candidate is APVO436, a bispecific T-cell engaging antibody candidate that is in Phase 1/1b clinic...

Founded: 2016
Full Time Employees: 80
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends